{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:09:49Z","timestamp":1791407389001,"version":"4.3.3"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T00:00:00Z","timestamp":1646784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Post-traumatic stress disorder (PTSD) is a serious stress-related disorder caused by traumatic experiences. However, identifying a key therapy that can be used for PTSD treatment remains difficult. Ketamine, a well-known dissociative anesthetic, is considered safe to be used in anesthesia, pain management, and antidepressant actions since 1970. At present, it is still controversial whether PTSD can be treated with ketamine. The authors performed a meta-analysis to determine whether the use of perioperative ketamine lowers the incidence of PTSD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cochrane Central Register of Controlled Trials, Embase, PubMed, and Web of Science were searched to examine the use of ketamine for the treatment of PTSD among soldiers with combating experience. Studies were included if they were randomized placebo-controlled, case-control, and cohort studies. The primary outcome was the incidence of PTSD in the later stage of the wounded or burn soldiers. The secondary outcome was the influence of ketamine on PTSD-scale scores for early and chronic PTSD, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our search yielded a total of three studies (\n                      <jats:italic>n<\/jats:italic>\n                      = 503 patients) comparing the use of ketamine (\n                      <jats:italic>n<\/jats:italic>\n                      = 349) to control (\n                      <jats:italic>n<\/jats:italic>\n                      = 154). The available evidence showed no significant difference in the incidence of PTSD between combatant soldiers on the battlefield with or without ketamine treatment (risk ratio = 0.81, 95% CI, 0.63\u20131.04;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.10). In 65 patients from three trials, ketamine was not only ineffective in treating early PTSD but also lead to exacerbation of the disease (risk ratio = 2.45, 95% CI, 1.33\u20133.58;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt; 0.001). However, in 91 patients from the other three trials, ketamine is effective in treating chronic PTSD (risk ratio = \u22123.66, 95% CI, \u22127.05 to \u22120.27;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Ketamine was not effective on lower the PTSD incidence for soldiers on the battlefield, nor on the PTSD-scale scores in early PTSD patients. However, it may improve the PTSD-scale scores for chronic conditions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Systematic Review Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42021255516<\/jats:ext-link>\n                      , PROSPERO, identifier: CRD42021255516.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpsyt.2022.813103","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T06:07:43Z","timestamp":1646806063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["The Multivariate Effect of Ketamine on PTSD: Systematic Review and Meta-Analysis"],"prefix":"10.3389","volume":"13","author":[{"given":"Rui","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulong","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"B1","volume-title":"Di-agnostic and Statistical Manual of Mental Disorders, 5th Edn. DSM-5","year":"2013"},{"key":"B2","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/da.22169","article-title":"Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys","volume":"31","author":"Karam","year":"2014","journal-title":"Depress Anxiety."},{"key":"B3","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/PSY.0b013e31803146d8","article-title":"Physical and mental comorbidity, disability, and suicidal behavior associated with posttraumatic stress disorder in a large community sample","volume":"69","author":"Sareen","year":"2007","journal-title":"Psychosom Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.janxdis.2010.11.010","article-title":"Prevalence and Axis I comorbidity of full and partial posttraumatic stress disorder in the United States: results from Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"25","author":"Pietrzak","year":"2011","journal-title":"J Anxiety Disord."},{"key":"B5","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4088\/JCP.v69n0611","article-title":"Pharmacotherapy of PTSD in the U.S. Department of Veterans Affairs: diagnostic- and symptom-guided drug selection","volume":"69","author":"Mohamed","year":"2008","journal-title":"J Clin Psychiatry."},{"key":"B6","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cpr.2015.02.007","article-title":"Psychological interventions for post-traumatic stress disorder and comorbid substance use disorder: a systematic review and meta-analysis","volume":"38","author":"Roberts","year":"2015","journal-title":"Clin Psychol Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2015.8370","article-title":"Psychotherapy for military-related PTSD: a review of randomized clinical trials","volume":"314","author":"Steenkamp","year":"2015","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/jts.22070","article-title":"Efficacy of fifteen emerging interventions for the treatment of posttraumatic stress disorder: a systematic review","volume":"29","author":"Metcalf","year":"2016","journal-title":"J Trauma Stress."},{"key":"B9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1056\/NEJMra012941","article-title":"Post-traumatic stress disorder","volume":"346","author":"Yehuda","year":"2002","journal-title":"N Engl J Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"8302","DOI":"10.1073\/pnas.1217750110","article-title":"Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder","volume":"110","author":"Mehta","year":"2013","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1176\/appi.ajp.2012.12040432","article-title":"Sleep disturbances as the hallmark of PTSD: where are we now?","volume":"170","author":"Germain","year":"2013","journal-title":"Am J Psychiatry."},{"key":"B12","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","article-title":"Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk","volume":"71","author":"Eraly","year":"2014","journal-title":"JAMA Psychiatry."},{"key":"B13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamapsychiatry.2015.0922","article-title":"Association of predeployment heart rate variability with risk of postdeployment posttraumatic stress disorder in active-duty marines","volume":"72","author":"Minassian","year":"2015","journal-title":"JAMA Psychiatry."},{"key":"B14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/npp.2015.266","article-title":"The genetics of stress-related disorders: PTSD, depression, and anxiety disorders","volume":"41","author":"Smoller","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1017\/S0033291715002159","article-title":"Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study","volume":"46","author":"Hu","year":"2016","journal-title":"Psychol Med."},{"key":"B16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1111\/pan.13526","article-title":"Analysis of 17 948 pediatric patients undergoing procedural sedation with a combination of intranasal dexmedetomidine and ketamine","volume":"29","author":"Yang","year":"2019","journal-title":"Paediatr Anaesth."},{"key":"B17","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1258\/002367781780959107","article-title":"Ketamine alone and combined with diazepam or xylazine in laboratory animals: a 10 year experience","volume":"15","author":"Green","year":"1981","journal-title":"Lab Anim."},{"key":"B18","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1532-950X.1998.tb00145.x","article-title":"Epidural injection of ketamine for perineal analgesia in the horse","volume":"27","author":"Gomez de Segura","year":"1998","journal-title":"Vet Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00115550-199823030-00010","article-title":"Intrathecal anesthesia with ketamine","volume":"23","author":"Hawksworth","year":"1998","journal-title":"Reg Anesth Pain Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1046\/j.1365-2044.2000.01472.x","article-title":"Effects of intrathecal ketamine added to bupivacaine for spinal anaesthesia","volume":"55","author":"Kathirvel","year":"2000","journal-title":"Anaesthesia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pain.2003.07.001","article-title":"Safety and efficacy of intranasal ketamine for the treatment of breakthrough pain in patients with chronic pain: a randomized, double-blind, placebo-controlled, crossover study","volume":"108","author":"Carr","year":"2004","journal-title":"Pain."},{"key":"B22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/ejp.624","article-title":"Efficacy and safety of oral ketamine for the relief of intractable chronic pain: a retrospective 5-year study of 51 patients","volume":"19","author":"Marchetti","year":"2015","journal-title":"Eur J Pain."},{"key":"B23","doi-asserted-by":"publisher","first-page":"315941","DOI":"10.1155\/2012\/315941","article-title":"Danger signals activating the immune response after trauma","author":"Hirsiger","year":"2012","journal-title":"Mediators Inflamm."},{"key":"B24","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2014.03.026","article-title":"A randomized controlled trial of intranasal ketamine in major depressive disorder","volume":"76","author":"Lapidus","year":"2014","journal-title":"Biol Psychiatry."},{"key":"B25","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1176\/appi.ajp.2020.20050596","article-title":"A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder","volume":"178","author":"Feder","year":"2021","journal-title":"Am J Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1001\/jamapsychiatry.2014.62","article-title":"Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical trial","volume":"71","author":"Feder","year":"2014","journal-title":"JAMA Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/anae.13832","article-title":"Heterogeneity in meta-analyses. Comparing apples and oranges?","volume":"72","author":"Choi","year":"2017","journal-title":"Anaesthesia."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2470547020981670","DOI":"10.1177\/2470547020981670","article-title":"Low dose ketamine infusion for comorbid posttraumatic stress disorder and chronic pain: a randomized double-blind clinical trial","volume":"4","author":"Dadabayev","year":"2020","journal-title":"Chronic Stress (Thousand Oaks)."},{"key":"B31","doi-asserted-by":"publisher","first-page":"S195","DOI":"10.1097\/TA.0b013e318160ba1d","article-title":"The correlation between ketamine and posttraumatic stress disorder in burned service members","volume":"64","author":"McGhee","year":"2008","journal-title":"J Trauma."},{"key":"B32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7205\/MILMED-D-13-00481","article-title":"The intraoperative administration of ketamine to burned U","volume":"179","author":"Maani","year":"2014","journal-title":"Mil Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/anae.14079","article-title":"A retrospective study of ketamine administration and the development of acute or post-traumatic stress disorder in 274 war-wounded soldiers","volume":"72","author":"Mion","year":"2017","journal-title":"Anaesthesia."},{"key":"B34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4103\/2542-3932.211589","article-title":"Trauma Interventions using Mindfulness Based Extinction and Reconsolidation (TIMBER) psychotherapy prolong the therapeutic effects of single ketamine infusion on posttraumatic stress disorder and comorbid depression: a pilot randomized, placebo-controlled, crossover clinical trial","volume":"2","author":"Pradhan","year":"2017","journal-title":"Asia Pac Clin Transl Nerv Syst Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.bbapap.2018.03.006","article-title":"d-Serine is a potential biomarker for clinical response in treatment of post-traumatic stress disorder using (R,S)-ketamine infusion and TIMBER psychotherapy: a pilot study","volume":"1866","author":"Pradhan","year":"2018","journal-title":"Biochim Biophys Acta Proteins Proteom."},{"key":"B36","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1007\/s00213-005-0094-4","article-title":"Effects of peritraumatic ketamine medication on early and sustained posttraumatic stress symptoms in moderately injured accident victims","volume":"182","author":"Schonenberg","year":"2005","journal-title":"Psychopharmacology (Berl)."},{"key":"B37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1177\/0269881107082481","article-title":"Ketamine aggravates symptoms of acute stress disorder in a naturalistic sample of accident victims","volume":"22","author":"Schonenberg","year":"2008","journal-title":"J Psychopharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.biopsych.2013.04.019","article-title":"Transient resolution of treatment-resistant posttraumatic stress disorder following ketamine infusion","volume":"74","author":"D'Andrea","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.biopsych.2012.10.017","article-title":"Acute stress symptoms do not worsen in posttraumatic stress disorder and abuse with a single subanesthetic dose of ketamine","volume":"73","author":"Zeng","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"S122","DOI":"10.1016\/j.biopsych.2019.03.305","article-title":"PTSD augmented psychotherapy with ketamine (KPE) - first results","volume":"10","author":"Duek","year":"2019","journal-title":"Biol Psychiatry."},{"key":"B41","doi-asserted-by":"publisher","first-page":"S217","DOI":"10.1016\/j.biopsych.2020.02.563","article-title":"Repeated sub-anesthetic ketamine to enhance prolonged exposure therapy in post-traumatic stress disorder: a Proof-Of-Concept Study","volume":"87","author":"Shiroma","year":"2020","journal-title":"Biol Psychiatry."},{"key":"B42","first-page":"19","article-title":"Ketamine and the pursuit of rapid-acting antidepressants for the treatment of depression and PTSD symptoms","author":"Krystal","year":"2016","journal-title":"Int J Neuropsychopharmacol."},{"key":"B43","first-page":"110","article-title":"Analgesia for days with low dose ketamine vs ketorolac in chronic pain and PTSD patients","volume":"45","author":"Kato","year":"2020","journal-title":"Neuropsychopharmacology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1177\/1534650121990894","article-title":"Ketamine-assisted psychotherapy for PTSD related to racial discrimination","volume":"20","author":"Halstead","year":"2021","journal-title":"Clin Case Stud."},{"key":"B45","doi-asserted-by":"publisher","first-page":"17m11634","DOI":"10.4088\/JCP.17m11634","article-title":"Efficacy, safety, and durability of repeated ketamine infusions for comorbid posttraumatic stress disorder and treatment-resistant depression","volume":"79","author":"Albott","year":"2018","journal-title":"J Clin Psychiatry."},{"key":"B46","first-page":"271","article-title":"High-dose ketamine infusion for the treatment of posttraumatic stress disorder in combat veterans","volume":"31","author":"Ross","year":"2019","journal-title":"Ann Clin Psychiatry."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2470547020980681","DOI":"10.1177\/2470547020980681","article-title":"Ketamine normalizes the structural alterations of inferior frontal gyrus in depression","volume":"4","author":"Dai","year":"2020","journal-title":"Chronic Stress (Thousand Oaks)."},{"key":"B48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1159\/000507095","article-title":"Continuous ketamine infusion for pain as an opportunity for psychotherapy for PTSD: a case series of ketamine-enhanced psychotherapy for PTSD and pain (KEP-P2)","volume":"89","author":"Keizer","year":"2020","journal-title":"Psychother Psychosom."},{"key":"B49","volume-title":"The PTSD Checklistcivilian Version (PCL-C)","author":"Weathers","year":"1994"},{"key":"B50","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/da.1029","article-title":"Clinician-administered PTSD scale: a review of the first ten years of research","volume":"13","author":"Weathers","year":"2001","journal-title":"Depress Anxiety."},{"key":"B51","first-page":"399","article-title":"The impact of event scale-revised","volume-title":"Assessing Psychological Trauma and PTSD","author":"Weiss","year":"1996"},{"key":"B52","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1037\/1040-3590.12.1.61","article-title":"Acute Stress Disorder Scale: a self-report measure of acute stress disorder","volume":"12","author":"Bryant","year":"2000","journal-title":"Psychol Assess."},{"key":"B53","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.biopsych.2013.04.027","article-title":"Repeated ketamine exposure induces an enduring resilient phenotype in adolescent and adult rats","volume":"74","author":"Parise","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4196\/kjpp.2016.20.4.357","article-title":"Effects of systemic administration of ibuprofen on stress response in a rat model of post-traumatic stress disorder","volume":"20","author":"Lee","year":"2016","journal-title":"Korean J Physiol Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","article-title":"mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists","volume":"329","author":"Li","year":"2010","journal-title":"Science."},{"key":"B56","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.biopsych.2010.12.015","article-title":"Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure","volume":"69","author":"Li","year":"2011","journal-title":"Biol Psychiatry."},{"key":"B57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.pnpbp.2016.03.009","article-title":"Role of glutamate receptors and glial cells in the pathophysiology of treatment-resistant depression","volume":"70","author":"Kim","year":"2016","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.813103\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T06:07:55Z","timestamp":1646806075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.813103\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":57,"alternative-id":["10.3389\/fpsyt.2022.813103"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.813103","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.13.21258836","asserted-by":"object"}]},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]},"article-number":"813103"}}